专利检索 ap:("Jiangsu Hengrui Pharmaceuticals Co., Ltd." OR "Shanghai Senhui Medicine Co., Ltd." OR "Retrolead (Shanghai) Biopharma Co., Ltd.") AND inv:"WU, Daize" 第 1 页

1.

发明公开
PYRIDONE COMPOUND HAVING INTEGRASE INHIBITORY ACTIVITY AND PHARMACEUTICAL USE THEREOF 审中-实审

公开(公告)号：EP4389745A1

公开(公告)日：2024-06-26

申请号：EP22815335.9

申请日：2022-06-02

申请人： Jiangsu Hengrui Pharmaceuticals Co., Ltd. , Shanghai Senhui Medicine Co., Ltd. , Retrolead (Shanghai) Biopharma Co., Ltd.

发明人： ZHU, Lingjian , HONG, Min , TAO, Weifeng , WU, Daize , PAN, Xiaoyu , GAO, Lu , HUANG, Jian

IPC分类号： C07D471/00 , C07D487/00 , C07D495/00 , C07D497/00 , C07D239/00 , C07D241/36 , A61K31/50 , A61K31/495 , A61P31/18

CPC分类号： A61K31/495 , A61K31/50 , A61P31/18 , C07D239/00 , C07D241/36 , C07D471/00 , C07D487/00 , C07D495/00 , C07D497/00

摘要： The present disclosure provides a pyridone compound having integrase inhibitory activity and a pharmaceutical use thereof. Specifically, the present disclosure provides a compound having a structure shown as formula I or a pharmaceutically acceptable salt thereof, which can be used to treat human immunodeficiency (HIV) infection.